News

The not approvable letter was previously issued by the FDA to Jerini in 2008 for Firazyr as the treatment for acute attacks of hereditary angioedema (HAE). Firazyr is

The collaboration is expected to enhance the drug development projects and the ongoing Harvard research projects by creating a drug discovery bridge between academia and industry. Under Harvard-UCB

The FDA said Rhucin BLA was not sufficiently complete to enable a critical medical review. Additionally, it also said that thedata provided to the FDA from the previous

As part of an international collaboration reaching from Singapore to California, the scientists examined the DNA of more than 60 people with MSSE and 110 of their unaffected

KUR-023 is delivered from a double barrelled syringe with a mixing spray tip. The product candidate is delivered as a spray which then arrives on the dura as

NerBloc, a botulinum toxin type B neuromuscular-blocking agent, has been approved by the Japanese regulatory authority in 21 January 2011. NerBloc has showed improvement in TWSTRS (Toronto Western

BMP Sunstone stockholders will now receive $10 per share in cash for common stock shares they owned prior to the effective time of the merger. Beijing-based BMP Sunstone,

Martek is involved in the innovation, development, production and sale of high-value products from microbial sources which promote health and wellness through nutrition. The transaction is part of

Under the pact, Selcia has used its proprietary CEfrag technique and has identified new and weak affinity hits from Selcia’s Fragment Library. Selcia claims that its CEfrag technology